Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Sponsor
University of Magdeburg
Study ID
NCT00385125
Phase
PHASE2
Status
Unknown

Conditions

  • Lymphoma, High-Grade

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Phase II study for treatment of patients with relapsed or primary refractory aggressive B- cell NHL and anthracycline chemotherapy pretreatment, who received or did not qualify for autologous stem cell transplantation.

Key Dates

Start date
Aug 31, 2004
Status verified
Oct 2006
Completion
Aug 31, 2010

Study Design

Enrollment
30 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

response rate

Central Contacts